BioShin
Shanghai
About BioShin
BioShin is a wholly owned subsidiary of Biohaven Pharmaceuticals, a public biotech company. BioShin is a clinical stage biopharmaceutical company focused on developing medicines. It has proven leadership from global industry and academic settings and a portfolio of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases, including rare disorders.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $60.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2020)
- Website: bioshin.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/bioshin-17796 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.